StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.31+0.17 (+7.94%)

Close on Nov 18, 2026Market cap $39.39MP/E –Yield –

Veru operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Veru's operating income for the twelve months ending Jun 30, 2026 was -$19.19M. For fiscal 2025 it was -$24.75M. The highest annual figure on record is $12.97M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$24.75M–
FY2024Sep 30, 2024-$36.17M–
FY2023Sep 30, 2023-$93.78M–
FY2022Sep 30, 2022-$83.49M-743.6%
FY2021Sep 30, 2021$12.97M–
FY2020Sep 30, 2020-$14.75M–
FY2019Sep 30, 2019-$6.44M–
FY2018Sep 30, 2018-$20.87M–
FY2017Sep 30, 2017-$8.49M-381.4%
FY2016Sep 30, 2016$3.02M-54.4%
FY2015Sep 30, 2015$6.62M+68.7%
FY2014Sep 30, 2014$3.92M-59.9%
FY2013Sep 30, 2013$9.79M-10.5%
FY2012Sep 30, 2012$10.94M+232.0%
FY2011Sep 30, 2011$3.30M-24.2%
FY2010Sep 30, 2010$4.35M-7.8%
FY2009Sep 30, 2009$4.72M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$7.71M–
Q2 FY2026CQ1 2026Mar 31, 2026-$7.22M–
Q1 FY2026CQ4 2025Dec 31, 2025-$5.42M–
Q4 FY2025CQ3 2025Sep 30, 2025$1.17M–
Q3 FY2025CQ2 2025Jun 30, 2025-$7.55M–
Q2 FY2025CQ1 2025Mar 31, 2025-$8.12M–
Q1 FY2025CQ4 2024Dec 31, 2024-$10.25M–
Q4 FY2024CQ3 2024Sep 30, 2024-$9.34M–
Q3 FY2024CQ2 2024Jun 30, 2024-$10.55M–
Q2 FY2024CQ1 2024Mar 31, 2024-$8.89M–
Q1 FY2024CQ4 2023Dec 31, 2023-$7.39M–
Q4 FY2023CQ3 2023Sep 30, 2023-$8.18M–
Q3 FY2023CQ2 2023Jun 30, 2023-$13.74M–
Q2 FY2023CQ1 2023Mar 31, 2023-$34.41M–
Q1 FY2023CQ4 2022Dec 31, 2022-$37.45M–
Q4 FY2022CQ3 2022Sep 30, 2022-$44.94M–
Q3 FY2022CQ2 2022Jun 30, 2022-$21.82M–
Q2 FY2022CQ1 2022Mar 31, 2022-$11.76M–
Q1 FY2022CQ4 2021Dec 31, 2021-$4.96M-125.9%
Q4 FY2021CQ3 2021Sep 30, 2021-$1.87M–
Q3 FY2021CQ2 2021Jun 30, 2021-$2.87M–
Q2 FY2021CQ1 2021Mar 31, 2021-$1.47M–
Q1 FY2021CQ4 2020Dec 31, 2020$19.19M–
Q4 FY2020CQ3 2020Sep 30, 2020-$11.27M–
Q3 FY2020CQ2 2020Jun 30, 2020-$1.39M–
Q2 FY2020CQ1 2020Mar 31, 2020-$299.68K–
Q1 FY2020CQ4 2019Dec 31, 2019-$1.78M–
Q4 FY2019CQ3 2019Sep 30, 2019-$1.46M–
Q3 FY2019CQ2 2019Jun 30, 2019-$1.84M–
Q2 FY2019CQ1 2019Mar 31, 2019-$2.12M–
Q1 FY2019CQ4 2018Dec 31, 2018-$1.01M–
Q4 FY2018CQ3 2018Sep 30, 2018-$3.77M–
Q3 FY2018CQ2 2018Jun 30, 2018-$4.96M–
Q2 FY2018CQ1 2018Mar 31, 2018-$4.70M–
Q1 FY2018CQ4 2017Dec 31, 2017-$7.44M–
Q4 FY2017CQ3 2017Sep 30, 2017-$2.77M–
Q3 FY2017CQ2 2017Jun 30, 2017-$1.27M–
Q2 FY2017CQ1 2017Mar 31, 2017-$2.58M–
Q1 FY2017CQ4 2016Dec 31, 2016-$1.87M–
Q4 FY2016CQ3 2016Sep 30, 2016-$292.99K–

More Veru figures

See a number that looks wrong?